N/A
N=64
Corticosteroid Injection for Common Upper Extremity Problems
Lateral Elbow Pain
Bottom Line
View on ClinicalTrials.gov: NCT00438672 ↗Enrolled (actual)
64
Serious AEs
0.0%
Results posted
May 2012
Primary outcome: Primary: Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire — 18; 13 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Placebo Injection (Drug); Steroid (dexamethasone) Injection (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Massachusetts General Hospital
- Primary completion
- May 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire |
18; 13 | — |
| PRIMARY Visual Analog Scale for Pain |
2.4; 1.7 | — |
Summary
The purpose of the study is to compare the effectiveness of a steroid injection to a placebo (inactive substance) in the treatment of lateral elbow pain, deQuervain's tendonitis, or base of the thumb carpometacarpal (CMC) arthritis. We are also trying to identify which personality factors and mindsets influence perceptions of elbow, wrist and hand pain. We hope to enroll 213 subjects in this study.
Eligibility Criteria
Inclusion Criteria
- Age 18 to 64 years
- onset of pain within the past 6 months
- willing to try a steroid injection in the elbow
Exclusion Criteria
- systemic inflammatory diseases (e.g., rheumatoid arthritis)
- pregnancy
- prior steroid injection, iontophoresis treatments with corticosteroids, or surgery for their pain
- history of adverse reaction to lidocaine
Data sourced from ClinicalTrials.gov (NCT00438672). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.